These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32626829)

  • 1. Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis.
    Young S; Tariq R; Provenza J; Satapathy SK; Faisal K; Choudhry A; Friedman SL; Singal AK
    Hepatol Commun; 2020 Jul; 4(7):953-972. PubMed ID: 32626829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
    Wei JL; Leung JC; Loong TC; Wong GL; Yeung DK; Chan RS; Chan HL; Chim AM; Woo J; Chu WC; Wong VW
    Am J Gastroenterol; 2015 Sep; 110(9):1306-14; quiz 1315. PubMed ID: 26215532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.
    Chen F; Esmaili S; Rogers GB; Bugianesi E; Petta S; Marchesini G; Bayoumi A; Metwally M; Azardaryany MK; Coulter S; Choo JM; Younes R; Rosso C; Liddle C; Adams LA; Craxì A; George J; Eslam M
    Hepatology; 2020 Apr; 71(4):1213-1227. PubMed ID: 31442319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial clustering of nonalcoholic fatty liver disease in first-degree relatives of adults with lean nonalcoholic fatty liver disease.
    Niltwat S; Limwongse C; Charatcharoenwitthaya N; Bunditvorapoom D; Bandidniyamanon W; Charatcharoenwitthaya P
    Liver Int; 2023 Dec; 43(12):2713-2726. PubMed ID: 37804066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonobese Fatty Liver Disease.
    Kim D; Kim WR
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):474-485. PubMed ID: 27581063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis.
    Alam S; Eslam M; Skm Hasan N; Anam K; Chowdhury MAB; Khan MAS; Hasan MJ; Mohamed R
    JGH Open; 2021 Nov; 5(11):1236-1249. PubMed ID: 34816009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
    Hepatol Commun; 2018 Jan; 2(1):48-57. PubMed ID: 29404512
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Salameh H; Hanayneh MA; Masadeh M; Naseemuddin M; Matin T; Erwin A; Singal AK
    J Clin Transl Hepatol; 2016 Sep; 4(3):175-191. PubMed ID: 27777887
    [No Abstract]   [Full Text] [Related]  

  • 15. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
    Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
    Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Luo JJ; Cao HX; Yang RX; Zhang RN; Pan Q
    World J Clin Cases; 2018 Sep; 6(10):355-364. PubMed ID: 30283798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Shi Y; Wang Q; Sun Y; Zhao X; Kong Y; Ou X; Jia J; Wu S; You H
    J Clin Gastroenterol; 2020 Apr; 54(4):378-387. PubMed ID: 31651571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.